INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 447m ago
House PTR46m ago
SEC 13F46m ago
Robinhood Chain45m ago

Results

82,097 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MT
Munsey Joshua ToddChief Financial Officer
AMRAlpha Metallurgical Resources, Inc.
Tax withholding
F$47K
203 sh
Jan 24, 2026
Page 1662 of 2053
← PrevNext →
Jan 27, 2026
traded Jan 24, 2026
+3d
SEC Form 4

Evidence

9
LC
Lee Orraparn C.EVP - Accounting
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Tax withholding
F$5,671
95 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

9
LS
Lepori StephanieCAO & Chief Admin. Officer
CZRCaesars Entertainment, Inc.
Grant or award
A—
38.7K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

9
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$270K
1,988 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

7
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
51.9K sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

6
BM
Boyd William M IIIChief Strategy Officer
SYMSymbotic Inc.
Option exercise
M—
2,910 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$131K
951 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$131K
950 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

5
FG
Freve Maria GSee Remarks
SYMSymbotic Inc.
Grant or award
A—
13.8K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

5
AT
Alsbrook Madeleine ThorpEVP - Talent Management
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Tax withholding
F$7,760
130 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

5
TJ
Twomey Cormac JEVP, Global Ops & Delivery
CNXCConcentrix Corp
Tax withholding
F$12K
292 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

5
MA
Modi Rajeev A.SEE REMARKS
ELANElanco Animal Health Inc
Grant or award
A$1,415
58 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

5
HE
Horn Daniel E.Chief Commercial Officer
AMRAlpha Metallurgical Resources, Inc.
Tax withholding
F$46K
198 sh
Jan 24, 2026Jan 27, 2026
traded Jan 24, 2026
+3dSEC Form 4

Evidence

5
KJ
Kuffner JamesCHIEF TECHNOLOGY OFFICER
SYMSymbotic Inc.
Grant or award
A—
30.7K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

5
KJ
Kuffner JamesCHIEF TECHNOLOGY OFFICER
SYMSymbotic Inc.
Grant or award
A—
61.4K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

5
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
1,500 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

5
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$802K
51.9K sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

5
AT
Alsbrook Madeleine ThorpEVP - Talent Management
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Disposition to issuer
D—
1,120 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$6,652
50 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$6,652
50 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$13K
100 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$13K
100 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

2
BM
Boyd William M IIIChief Strategy Officer
SYMSymbotic Inc.
Option exercise
M—
8,826 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

2
BM
Boyd William M IIIChief Strategy Officer
SYMSymbotic Inc.
Grant or award
A—
15.3K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

2
BM
Boyd William M IIIChief Strategy Officer
SYMSymbotic Inc.
Grant or award
A—
30.7K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

2
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$126K
8,135 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

0
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
8,135 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

62
RG
Rooney Robert GeraldDirector
NONENONETCW Private Asset Income Fund
Open-market purchase
BUY$281K
28.1K sh
Nov 10, 2025Jan 26, 2026
traded Nov 10, 2025
+77dSEC Form 4

Evidence

59
RG
Rooney Robert GeraldDirector
NONENONETCW Private Asset Income Fund
Open-market purchase
BUY$113K
11.3K sh
Nov 10, 2025Jan 26, 2026
traded Nov 10, 2025
+77dSEC Form 4

Evidence

41
CL
Cheng LawrenceDirector
GMEGameStop Corp.
Open-market purchase
BUY$114K
5,000 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

36
CD
Crane Benton DelossDirector
ANGXAngel Studios, Inc.
Derivative conversion
C—
200.0K sh
Nov 26, 2025Jan 26, 2026
traded Nov 26, 2025
+61dSEC Form 4

Evidence

35
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$1.00M
9,525 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$2.81M
7,200 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$1.00M
9,525 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$2.00M
19.1K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$1.99M
5,128 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$3.32M
8,500 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

33
TA
Tpg Gp A, Llc10% Owner
SIONSionna Therapeutics, Inc.
Open-market sale
SELL$10.00M
250.0K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

33
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale
SELL$777K
1,577 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

32
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$864K
2,200 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence